Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026764 (
multiple myeloma
)
36,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
VSTM1
(
V-set and transmembrane domain containing 1
) is a novel membrane molecule identified from immunogenomics, which has two main isoforms,
VSTM1
-v1 and
VSTM1
-v2.
VSTM1
-v1 is a type I transmembrane protein, and
VSTM1
-v2 is a classical secretory protein, lacking only the transmembrane domain compared with
VSTM1
-v1. This study was designed to generate
VSTM1
-specific monoclonal antibodies (MAbs) for further exploration of its expression and function. Mice were immunized with two recombinant prokaryotic proteins of GST-
VSTM1
-v2 and
VSTM1
-v2 without any tag. Hybridomas were generated by the fusion of the splenocytes to Sp2/0
myeloma
cells. Three hybridoma cell lines (2C11, 6E11, and 7A8) stable in secreting anti-
VSTM1
MAb were obtained and further characterized. All three MAbs were IgG2b isotype and effective in detecting the overexpressed
VSTM1
in both Western blot and flow cytometry assays, while recognizing the endogenous
VSTM1
in Western blot analysis only. These MAbs could be helpful in the basic study of
VSTM1
and in revealing the interesting conformation difference between the overexpressed and endogenous proteins.
...
PMID:Preparation and characterization of monoclonal antibodies against VSTM1. 2390 23